alleyoop Posted August 17, 2010 Posted August 17, 2010 The FDA Alert on Serotonin Syndrome With Use of Triptans Combined With Selective Serotonin Reuptake Inhibitors or Selective Serotonin-Norepinephrine Reuptake Inhibitors: American Headache Society Position Paper http://onlinelibrary.wiley.com/doi/10.1111/j.1526-4610.2010.01691.x/abstract Quote
Recommended Posts
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.